Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q4 2018 13F Holders as of 12/31/2018

Type / Class
Equity / SPONDS ADR
Number of holders
74
Total Shares
69.1M
Shares change
+3.54M
Total reported value, excl. options
$397M
Value change
-$4.29M
Put/Call ratio
0
Number of buys
34
Number of sells
-46
Price
$5.75
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.